GSDMD and serum lipopolysaccharide activity: We used an endothelial cell–specific Gsdmd shRNA-knockdown AAV9 vector to inhibit endothelial GSDMD levels, thereby protecting mice with endotoxemia and sepsis from ALI and mortality.